640 related articles for article (PubMed ID: 17159922)
1. Multi-targeting by monotherapeutic antibacterials.
Silver LL
Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
[TBL] [Abstract][Full Text] [Related]
2. Novel target sites in bacteria for overcoming antibiotic resistance.
Black MT; Hodgson J
Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
[TBL] [Abstract][Full Text] [Related]
3. Targeting non-multiplying organisms as a way to develop novel antimicrobials.
Coates AR; Hu Y
Trends Pharmacol Sci; 2008 Mar; 29(3):143-50. PubMed ID: 18262665
[TBL] [Abstract][Full Text] [Related]
4. Drugs for bad bugs: confronting the challenges of antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Pompliano DL
Nat Rev Drug Discov; 2007 Jan; 6(1):29-40. PubMed ID: 17159923
[TBL] [Abstract][Full Text] [Related]
5. Whither antibacterial drug discovery?
Projan SJ
Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
[No Abstract] [Full Text] [Related]
6. Old and new targets of antibacterial therapy.
Dbaibo GS
J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
[TBL] [Abstract][Full Text] [Related]
7. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
Fernandes P; Pizza M
Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
[No Abstract] [Full Text] [Related]
8. Late stage antibacterial drugs in the clinical pipeline.
Projan SJ; Bradford PA
Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
[TBL] [Abstract][Full Text] [Related]
9. What is inadequate antibacterial therapy?
Moellering RC
Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
[No Abstract] [Full Text] [Related]
10. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance.
Gyssens IC
Clin Microbiol Infect; 2008 Oct; 14(10):889-91. PubMed ID: 18828849
[TBL] [Abstract][Full Text] [Related]
11. The antibiotic resistome: challenge and opportunity for therapeutic intervention.
Martínez JL
Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941
[TBL] [Abstract][Full Text] [Related]
12. Bacterial targets to antimicrobial leads and development candidates.
Rogers BL
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
[TBL] [Abstract][Full Text] [Related]
13. [New targets in the field of antibacterial agents. Prospective aspects].
Desnottes JF
Ann Pharm Fr; 1999 Mar; 57(2):177-82. PubMed ID: 10365475
[TBL] [Abstract][Full Text] [Related]
14. Bacterial tyrosine kinases: novel targets for antibacterial therapy?
Cozzone AJ
Trends Microbiol; 2009 Dec; 17(12):536-43. PubMed ID: 19853456
[TBL] [Abstract][Full Text] [Related]
15. Development of new antibacterials: a laudable aim, but what is the value?
Tillotson GS
Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
[No Abstract] [Full Text] [Related]
16. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ
FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283
[TBL] [Abstract][Full Text] [Related]
17. When will the genomics investment pay off for antibacterial discovery?
Mills SD
Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
[TBL] [Abstract][Full Text] [Related]
18. The global need for effective antibiotics: challenges and recent advances.
Högberg LD; Heddini A; Cars O
Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
[TBL] [Abstract][Full Text] [Related]
19. Has nature already identified all useful antibacterial targets?
Bumann D
Curr Opin Microbiol; 2008 Oct; 11(5):387-92. PubMed ID: 18804175
[TBL] [Abstract][Full Text] [Related]
20. Challenges of antibacterial discovery revisited.
Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
